Product NDC: | 0015-3072 |
Proprietary Name: | PLATINOL |
Non Proprietary Name: | cisplatin |
Active Ingredient(s): | 50 mg/50mL & nbsp; cisplatin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0015-3072 |
Labeler Name: | E.R. Squibb & Sons, L.L.C. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018057 |
Marketing Category: | NDA |
Start Marketing Date: | 20050101 |
Package NDC: | 0015-3072-97 |
Package Description: | 10 CARTON in 1 CARTON (0015-3072-97) > 1 VIAL in 1 CARTON > 50 mL in 1 VIAL |
NDC Code | 0015-3072-97 |
Proprietary Name | PLATINOL |
Package Description | 10 CARTON in 1 CARTON (0015-3072-97) > 1 VIAL in 1 CARTON > 50 mL in 1 VIAL |
Product NDC | 0015-3072 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cisplatin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20050101 |
Marketing Category Name | NDA |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | CISPLATIN |
Strength Number | 50 |
Strength Unit | mg/50mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |